NCT00543504 2020-06-30
Bevacizumab in Multiple Phase I Combinations
M.D. Anderson Cancer Center
Phase 1 Completed
Clinical Trials
3 trialsNCT00698841 2015-12-24
Study to Evaluate the Effect of Cetuximab on Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid Tumors
Eli Lilly and Company
Phase 2 Completed
NCT00940381 2015-11-18
Sirolimus and Cetuximab in Advanced Malignancies
M.D. Anderson Cancer Center
Phase 1 Completed